CBI To Probe Ex-Assistant Drugs Controller Misconduct: High Court

New Delhi: In a significant development, the High Court of Punjab and Haryana has directed the Central Bureau of Investigation (CBI) to take over the investigation of a case involving alleged cheating by a former Assistant Drugs Controller of Himachal Pradesh, Nishant Sareen, among others.

The case came to light following allegations that the official, despite being directed by the Supreme Court to surrender to the trial court within four weeks, continued to attend office. This act of defiance raised questions about the support he might have received from the investigating agency handling the case.

The High Court’s decision was influenced by the petitioner’s counsel highlighting potential obstructions in the investigation, including the frequent reassignment of Investigating Officers, especially before court hearings. The court observed these actions as deliberate attempts to impede the judicial process.

Acknowledging the gravity of the accusations, which include complicity of police officers, the High Court deemed it necessary for an independent body like the CBI to conduct a fair and unbiased investigation.

“Taking into consideration the entire facts of the case and very serious allegations made against all the respondents including police officers, it is a fit case where the investigation has to be handed over to an independent agency like CBI for the purpose of fair and unbiased investigation,” the court noted in the order.

This order marks a pivotal move towards ensuring the integrity of the judicial system and upholding the rule of law. The CBI’s involvement is expected to bring transparency to the proceedings and address the serious allegations leveled against the respondents.

Related Posts

Cancer cure must not be hostage to Big Pharma

In recent years, immunotherapy has expanded the limits of cancer treatment. Therapies that harness the body’s immune system to fight malignant cells have improved survival rates in cancers once considered…

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Pune:- A woman, 34, dia­gnosed with poly­cystic ovary syn­drome, or PCOS, as a teen­ager, saw her first nat­ural men­strual cycle in Feb­ru­ary—six months after start­ing Moun­jaro for weight man­age­ment. This…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients